Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Axsome Therapeutics Q3 EPS $(0.93) Beats $(0.95) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(0.95) by 2.11 percent. This is a 52.46 percent decrease over losses of $(0.61) per share
byLuke J Jacobi
November 8, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.93) per share which beat the analyst consensus estimate of $(0.95) by 2.11 percent. This is a 52.46 percent decrease over losses of $(0.61) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts